After 2 years of close cooperation, the scientists of the Israeli AiVF firm and Embryolab Fertility Clinic introduced EMA, the new innovative system for advanced embryo selection.
EMA, combines AI, computer vision, and Big Data analytics and aims to revolutionize embryo selection and advance current reproductive scientists’ efficiency to identify the embryos with the best implantation potential.
In 2019, Embryolab was selected and proudly accepted the invitation of AIVF -experts in Artificial Intelligence- to actively participate in the design of the innovative EMA system. Embryolab, since 16 of November 2021, is the first Fertility Clinic in the world to have installed the integrated EMA system in order to evaluate its effectiveness in practice!
According to AiVF CEO Daniella Gilboa, “This is a great milestone for the Assisted Reproduction science. The power of data will help Clinical Embryology become even more effective for infertile couples.”
Dr. Nikos Christoforidis, MD, MSc, FRCOG, Consultant Obstetrician & Gynaecologist, Embryolab’s Clinical and Scientific Director, stated: “We are pleased to welcome these new developments. Technology is our best ally when treating infertility.”
Mrs. Alexia Chatziparasidou, MSc, PMI-RMP, Consultant Clinical Embryologist, Director of Embryolab Academy, Co-Founder of Embryolab Fertility Clinic, points out that “the EMA artificial intelligence system brings us to the new era of assisted reproduction where automation and high technology ensure more effective treatments!”
Mr. Achilleas Papatheodorou, PhD., M.Med.Sc., Senior Clinical Embryologist, ESHRE certified, Embryolab’s Lab Director, confirms: “The development of such a technologically innovative automation will significantly improve our ability to identify and select for transfer the embryos with the best chances for a healthy pregnancy. Embryolab’s Laboratory Team, all 12 Clinical Embryologists and Technologists, have been trained to make the most of EMA’s operation during the validation period always in close collaboration with our AIVF partners.”
Embryolab, inspired by its goals and vision and from the trust received by thousands of patients during its 18 years of operation, evolves its role and actively participates in the design, development and validation of high-tech products that revolutionize and optimize current practices.
We change lives,
We create families